2m 2m 2m 2m 2m 2m 2m
Kaya Hldgs (KAYS)
OTC
$0.01+$0.004 (+72.41%)
Price as of Jul 10, 2026- $6.9MMarket Cap
- -68.25%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Kaya Hldgs (KAYS)
$0.01+$0.004 (+72.41%)
KAYS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.01 | ||
Change | +$0.004 (+72.41%) | ||
Open | $0.01 | ||
High | $0.01 | ||
Low | $0.01 | ||
Previous Close | $0.01 | ||
Volume | 334 | ||
30-Day Average Volume | 12,805 | ||
1-Week Change | -45.62% | ||
1-Month Change | -49.87% | ||
1-Year Change | -68.25% | ||
3-Year Change | -81.24% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 686.4M | ||
Total Assets | $199,358.00 | ||
Market Cap | $6.9M | ||
Enterprise Value | $7.4M | ||
Period: QTR TTM FY | |||
Revenue | $5,408.00 | ||
Net Income | -$8.6M | ||
Free Cash Flow | -$67,710.00 | ||
EBIT | -$8.6M | ||
EBITDA | -$8.6M | ||
Net Working Capital | -$2.4M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | 1,361 | ||
P/B | -13 | ||
P/E | -0 | ||
PEG | N/A | ||
Price/Free Cash Flow | -101 | ||
Price/Operating Cash Flow | -101 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 12/15/2020 | ||